Two research studies assessed the effect of high doses of vitamin D on relapses and brain lesions.

New research has provided evidence that infection with the Epstein Barr virus acts as a trigger for people to develop MS.

In April 2020 we shared a research study with members of our Facebook group. The study was conducted by the University of Reading and looked at the impact of Covid-19 on people with multiple sclerosis. In this blog we take a look at the findings.

A potential treatment for multiple sclerosis uses mRNA technology, similar to two of the Covid-19 vaccines. Find out more about this research.

An update from the 2020 ECTRIMS and ACTRIMS, the largest annual MS research conference.

Clinical psychologist, Dr Sophie Day, discusses how self-compassion and resilience can help people with MS adjust to living with a long-term condition. She provides some practical strategies which, through a little bit of self reflection, encourage you to be kinder to, and more accepting of, yourself.

Results from a UK study suggest that a daily mug of cocoa made from dark chocolate could improve MS fatigue.

People with relapsing remitting MS starting early treatment with a disease modifying drug have a lower risk of converting to secondary progressive MS, according to a study of medical records.

In this blog, the MS Trust looks at some of the research so far, what’s possible now and where we might expect to see further progress in the future